Ahmadian A, Brogan A, Berman J, Sverdlov AL, Mercier G, Mazzini M, Govender P, Ruberg FL, Miller EJ. Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis. J Nucl Cardiol. 2014;21:925–39.

Article  PubMed  Google Scholar 

Mc Ardle BA, Leung E, Ohira H, Cocker MS, deKemp RA, DaSilva J, Birnie D, Beanlands RS, Nery PB. The role of F(18)-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosis. J Nucl Cardiol. 2013;20:297–306.

Article  CAS  PubMed  Google Scholar 

Osborne MT, Hulten EA, Singh A, Waller AH, Bittencourt MS, Stewart GC, Hainer J, Murthy VL, Skali H, Dorbala S, Di Carli MF, Blankstein R. Reduction in (1)(8)F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis. J Nucl Cardiol. 2014;21:166–74.

Article  PubMed  Google Scholar 

Sperry BW, Tamarappoo BK, Oldan JD, Javed O, Culver DA, Brunken R, Cerqueira MD, Hachamovitch R. Prognostic impact of extent, severity, and heterogeneity of abnormalities on (18)F-FDG PET scans for suspected cardiac sarcoidosis. JACC Cardiovasc Imaging. 2018;11:336–45.

Article  PubMed  Google Scholar 

Morimoto T, Azuma A, Abe S, Usuki J, Kudoh S, Sugisaki K, Oritsu M, Nukiwa T. Epidemiology of sarcoidosis in Japan. Eur Respir J. 2008;31:372–9.

Article  CAS  PubMed  Google Scholar 

Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, Muller-Quernheim J. Sarcoidosis. Lancet. 2014;383:1155–67.

Article  PubMed  Google Scholar 

Birnie DH. Cardiac sarcoidosis. Semin Respir Crit Care Med. 2020;41:626–40.

Article  PubMed  Google Scholar 

Birnie DH, Kandolin R, Nery PB, Kupari M. Cardiac manifestations of sarcoidosis: diagnosis and management. Eur Heart J. 2017;38:2663–70.

CAS  PubMed  Google Scholar 

Iwai K, Tachibana T, Takemura T, Matsui Y, Kitaichi M, Kawabata Y. Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan. Acta Pathol Jpn. 1993;43:372–6.

CAS  PubMed  Google Scholar 

Kusano K, Ishibashi K, Noda T, Nakajima K, Nakasuka K, Terasaki S, Hattori Y, Nagayama T, Mori K, Takaya Y, Miyamoto K, Nagase S, Aiba T, Yasuda S, Kitakaze M, Kamakura S, Yazaki Y, Morimoto SI, Isobe M, Terasaki F. Prognosis and outcomes of clinically diagnosed cardiac sarcoidosis without positive endomyocardial biopsy findings. JACC Asia. 2021;1:385–95.

Article  PubMed  PubMed Central  Google Scholar 

Nordenswan HK, Lehtonen J, Ekstrom K, Raisanen-Sokolowski A, Mayranpaa MI, Vihinen T, Miettinen H, Kaikkonen K, Haataja P, Kerola T, Rissanen TT, Kokkonen J, Alatalo A, Pietila-Effati P, Utriainen S, Kupari M. Manifestations and outcome of cardiac sarcoidosis and idiopathic giant cell myocarditis by 25-Year nationwide cohorts. J Am Heart Assoc. 2021;10:e019415.

Article  PubMed  PubMed Central  Google Scholar 

Fussner LA, Karlstedt E, Hodge DO, Fine NM, Kalra S, Carmona EM, Utz JP, Isaac DL, Cooper LT. Management and outcomes of cardiac sarcoidosis: a 20-year experience in two tertiary care centres. Eur J Heart Fail. 2018;20:1713–20.

Article  PubMed  Google Scholar 

Rosenbaum AN, Kolluri N, Elwazir MY, Kapa S, Abou Ezzeddine OF, Bois JP, Chareonthaitawee P, Schmidt TJ, Cooper LT. Identification of a novel presumed cardiac sarcoidosis category for patients at high risk of disease. Int J Cardiol. 2021;335:66–72.

Article  PubMed  Google Scholar 

Ekstrom K, Lehtonen J, Nordenswan HK, Mayranpaa MI, Raisanen-Sokolowski A, Kandolin R, Simonen P, Pietila-Effati P, Alatalo A, Utriainen S, Rissanen TT, Haataja P, Kokkonen J, Vihinen T, Miettinen H, Kaikkonen K, Kerola T, Kupari M. Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries. Eur Heart J. 2019;40:3121–8.

Article  PubMed  Google Scholar 

Vasaiwala SC, Finn C, Delpriore J, Leya F, Gagermeier J, Akar JG, Santucci P, Dajani K, Bova D, Picken MM, Basso C, Marcus F, Wilber DJ. Prospective study of cardiac sarcoid mimicking arrhythmogenic right ventricular dysplasia. J Cardiovasc Electrophysiol. 2009;20:473–6.

Article  PubMed  Google Scholar 

Niemela M, Uusitalo V, Poyhonen P, Schildt J, Lehtonen J, Kupari M. Incidence and predictors of atrial fibrillation in cardiac sarcoidosis: a multimodality imaging study. JACC Cardiovasc Imaging. 2022;15:1622–31.

Article  PubMed  Google Scholar 

Kruse MJ, Kovell L, Kasper EK, Pomper MG, Moller DR, Solnes L, Chen ES, Schindler TH. Myocardial blood flow and inflammatory cardiac sarcoidosis. JACC Cardiovasc Imaging. 2017;10:157–67.

Article  PubMed  Google Scholar 

Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation. 1978;58:1204–11.

Article  CAS  PubMed  Google Scholar 

Kouranos V, Tzelepis GE, Rapti A, Mavrogeni S, Aggeli K, Douskou M, Prasad S, Koulouris N, Sfikakis P, Wells A, Gialafos E. Complementary role of CMR to conventional screening in the diagnosis and prognosis of cardiac sarcoidosis. JACC Cardiovasc Imaging. 2017;10:1437–47.

Article  PubMed  Google Scholar 

Schupp JC, Freitag-Wolf S, Bargagli E, Mihailovic-Vucinic V, Rottoli P, Grubanovic A, Muller A, Jochens A, Tittmann L, Schnerch J, Olivieri C, Fischer A, Jovanovic D, Filipovic S, Videnovic-Ivanovic J, Bresser P, Jonkers R, O'Reilly K, Ho LP, Gaede KI, Zabel P, Dubaniewicz A, Marshall B, Kieszko R, Milanowski J, Gunther A, Weihrich A, Petrek M, Kolek V, Keane MP, O'Beirne S, Donnelly S, Haraldsdottir SO, Jorundsdottir KB, Costabel U, Bonella F, Wallaert B, Grah C, Peros-Golubicic T, Luisetti M, Kadija Z, Pabst S, Grohe C, Strausz J, Vasakova M, Sterclova M, Millar A, Homolka J, Slovakova A, Kendrick Y, Crawshaw A, Wuyts W, Spencer L, Pfeifer M, Valeyre D, Poletti V, Wirtz H, Prasse A, Schreiber S, Krawczak M and Muller-Quernheim J. Phenotypes of organ involvement in sarcoidosis. Eur Respir J. 2018;51:170991.

Kandolin R, Lehtonen J, Airaksinen J, Vihinen T, Miettinen H, Ylitalo K, Kaikkonen K, Tuohinen S, Haataja P, Kerola T, Kokkonen J, Pelkonen M, Pietila-Effati P, Utrianen S, Kupari M. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation. 2015;131:624–32.

Article  PubMed  Google Scholar 

Kupari M, Lehtonen J. POINT: should isolated cardiac sarcoidosis be considered a significant manifestation of sarcoidosis? Yes. Chest. 2021;160:36–8.

Article  PubMed  Google Scholar 

Okada DR, Bravo PE, Vita T, Agarwal V, Osborne MT, Taqueti VR, Skali H, Chareonthaitawee P, Dorbala S, Stewart G, Di Carli M, Blankstein R. Isolated cardiac sarcoidosis: A focused review of an under-recognized entity. J Nucl Cardiol. 2018;25:1136–46.

Article  PubMed  Google Scholar 

Juneau D, Nery P, Russo J, de Kemp RA, Leung E, Beanlands RSB, Birnie DH. How common is isolated cardiac sarcoidosis? Extra-cardiac and cardiac findings on clinical examination and whole-body (18)F-fluorodeoxyglucose positron emission tomography. Int J Cardiol. 2018;253:189–93.

Article  PubMed  Google Scholar 

Eldhagen P, Bobbio E, Darlington P, Grunewald J, Eklund A, Polte CL, Bergh N, Bollano E, Sorensson P, Kullberg S. Phenotypic and HLA-DRB1 allele characterization of Swedish cardiac sarcoidosis patients. Int J Cardiol. 2022;359:108–12.

Article  PubMed  Google Scholar 

Rosen NS, Pavlovic N, Duvall C, Wand AL, Griffin JM, Okada DR, Chrispin J, Tandri H, Mathai SC, Stern B, Pardo CA, Kasper EK, Sharp M, Chen ES, Gilotra NA. Cardiac sarcoidosis outcome differences: A comparison of patients with de novo cardiac versus known extracardiac sarcoidosis at presentation. Respir Med. 2022;198:106864.

Article  PubMed  Google Scholar 

Sadek MM, Yung D, Birnie DH, Beanlands RS, Nery PB. Corticosteroid therapy for cardiac sarcoidosis: a systematic review. Can J Cardiol. 2013;29:1034–41.

Article  PubMed  Google Scholar 

Baughman RP, Valeyre D, Korsten P, Mathioudakis AG, Wuyts WA, Wells A, Rottoli P, Nunes H, Lower EE, Judson MA, Israel-Biet D, Grutters JC, Drent M, Culver DA, Bonella F, Antoniou K, Martone F, Quadder B, Spitzer G, Nagavci B, Tonia T, Rigau D, Ouellette DR. ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir J. 2021;58(6):2004079.

Scheuermann RH, Ceusters W, Smith B. Toward an ontological treatment of disease and diagnosis. Summit Transl Bioinform. 2009;2009:116–20.

PubMed  PubMed Central  Google Scholar 

Papiris SA, Georgakopoulos A, Papaioannou AI, Pianou N, Kallergi M, Kelekis NL, Gialafos H, Manali ED, Chatziioannou S. Emerging phenotypes of sarcoidosis based on 18F-FDG PET/CT: a hierarchical cluster analysis. Expert Rev Respir Med. 2020;14:229–38.

Article  CAS  PubMed  Google Scholar 

Baughman RP, Scholand MB, Rahaghi FF. Clinical phenotyping: role in treatment decisions in sarcoidosis. Eur Respir Rev. 2020;29(155):190145.

Neville E, Walker AN, James DG. Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. Q J Med. 1983;52:525–33.

CAS  PubMed  Google Scholar 

Fu Y, Maianu L, Melbert BR, Garvey WT. Facilitative glucose transporter gene expression in human lymphocytes, monocytes, and macrophages: a role for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation. Blood Cells Mol Dis. 2004;32:182–90.

Article  CAS  PubMed  Google Scholar 

Okumura W, Iwasaki T, Toyama T, Iso T, Arai M, Oriuchi N, Endo K, Yokoyama T, Suzuki T, Kurabayashi M. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med. 2004;45:1989–98.

PubMed